154 related articles for article (PubMed ID: 30204534)
21. A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer.
Han B; Mehra R; Dhanasekaran SM; Yu J; Menon A; Lonigro RJ; Wang X; Gong Y; Wang L; Shankar S; Laxman B; Shah RB; Varambally S; Palanisamy N; Tomlins SA; Kumar-Sinha C; Chinnaiyan AM
Cancer Res; 2008 Sep; 68(18):7629-37. PubMed ID: 18794152
[TBL] [Abstract][Full Text] [Related]
22. Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition.
Han S; Brenner JC; Sabolch A; Jackson W; Speers C; Wilder-Romans K; Knudsen KE; Lawrence TS; Chinnaiyan AM; Feng FY
Neoplasia; 2013 Oct; 15(10):1207-17. PubMed ID: 24204199
[TBL] [Abstract][Full Text] [Related]
23. [Frequency and transcript variant analysis of gene fusions between TMPRSS2 and ETS transcription factor genes in prostate cancer].
Dai MJ; Chen LL; Zheng YB; Chen W; Tao ZH; Weng ZL; Wu XL; Li CD; Chen ZG; Chen XD; Shi SB
Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(10):669-73. PubMed ID: 18642766
[TBL] [Abstract][Full Text] [Related]
24. ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients.
Baena E; Shao Z; Linn DE; Glass K; Hamblen MJ; Fujiwara Y; Kim J; Nguyen M; Zhang X; Godinho FJ; Bronson RT; Mucci LA; Loda M; Yuan GC; Orkin SH; Li Z
Genes Dev; 2013 Mar; 27(6):683-98. PubMed ID: 23512661
[TBL] [Abstract][Full Text] [Related]
25. Potential downstream target genes of aberrant ETS transcription factors are differentially affected in Ewing's sarcoma and prostate carcinoma.
Camões MJ; Paulo P; Ribeiro FR; Barros-Silva JD; Almeida M; Costa VL; Cerveira N; Skotheim RI; Lothe RA; Henrique R; Jerónimo C; Teixeira MR
PLoS One; 2012; 7(11):e49819. PubMed ID: 23185447
[TBL] [Abstract][Full Text] [Related]
26. Characterization of TMPRSS2-ETS gene aberrations in androgen-independent metastatic prostate cancer.
Mehra R; Tomlins SA; Yu J; Cao X; Wang L; Menon A; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
Cancer Res; 2008 May; 68(10):3584-90. PubMed ID: 18483239
[TBL] [Abstract][Full Text] [Related]
27. Modulation of androgen receptor DNA binding activity through direct interaction with the ETS transcription factor ERG.
Wasmuth EV; Hoover EA; Antar A; Klinge S; Chen Y; Sawyers CL
Proc Natl Acad Sci U S A; 2020 Apr; 117(15):8584-8592. PubMed ID: 32220959
[TBL] [Abstract][Full Text] [Related]
28. Oncogenic ETS Factors in Prostate Cancer.
Nicholas TR; Strittmatter BG; Hollenhorst PC
Adv Exp Med Biol; 2019; 1210():409-436. PubMed ID: 31900919
[TBL] [Abstract][Full Text] [Related]
29. The Expression of Proto-Oncogene
Khosh Kish E; Choudhry M; Gamallat Y; Buharideen SM; D D; Bismar TA
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563163
[TBL] [Abstract][Full Text] [Related]
30. Comparison of MAPK specificity across the ETS transcription factor family identifies a high-affinity ERK interaction required for ERG function in prostate cells.
Selvaraj N; Kedage V; Hollenhorst PC
Cell Commun Signal; 2015 Feb; 13():12. PubMed ID: 25885538
[TBL] [Abstract][Full Text] [Related]
31. Androgen regulation of ETS gene fusion transcripts in prostate cancer.
Gasi D; Trapman J
Methods Mol Biol; 2011; 776():335-48. PubMed ID: 21796535
[TBL] [Abstract][Full Text] [Related]
32. Clonal evaluation of prostate cancer molecular heterogeneity in biopsy samples by dual immunohistochemistry and dual RNA in situ hybridization.
Dedigama-Arachchige P; Carskadon S; Li J; Loveless I; Alhamar M; Peabody JO; Stricker H; Chitale DA; Rogers CG; Menon M; Gupta NS; Bismar TA; Williamson SR; Palanisamy N
Mod Pathol; 2020 Sep; 33(9):1791-1801. PubMed ID: 32238875
[TBL] [Abstract][Full Text] [Related]
33. The peripheral zone of the prostate is more prone to tumor development than the transitional zone: is the ETS family the key?
Adler D; Lindstrot A; Ellinger J; Rogenhofer S; Buettner R; Perner S; Wernert N
Mol Med Rep; 2012 Feb; 5(2):313-6. PubMed ID: 22038307
[TBL] [Abstract][Full Text] [Related]
34. Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing.
Pflueger D; Terry S; Sboner A; Habegger L; Esgueva R; Lin PC; Svensson MA; Kitabayashi N; Moss BJ; MacDonald TY; Cao X; Barrette T; Tewari AK; Chee MS; Chinnaiyan AM; Rickman DS; Demichelis F; Gerstein MB; Rubin MA
Genome Res; 2011 Jan; 21(1):56-67. PubMed ID: 21036922
[TBL] [Abstract][Full Text] [Related]
35. --A high-throughput screen identifies inhibitors of the interaction between the oncogenic transcription factor ERG and the cofactor EWS.
Nicholas TR; Meng J; Greulich BM; Morris TS; Hollenhorst PC
PLoS One; 2020; 15(9):e0238999. PubMed ID: 32915889
[TBL] [Abstract][Full Text] [Related]
36. FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer.
Paulo P; Barros-Silva JD; Ribeiro FR; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR
Genes Chromosomes Cancer; 2012 Mar; 51(3):240-9. PubMed ID: 22081504
[TBL] [Abstract][Full Text] [Related]
37. COP1 is a tumour suppressor that causes degradation of ETS transcription factors.
Vitari AC; Leong KG; Newton K; Yee C; O'Rourke K; Liu J; Phu L; Vij R; Ferrando R; Couto SS; Mohan S; Pandita A; Hongo JA; Arnott D; Wertz IE; Gao WQ; French DM; Dixit VM
Nature; 2011 May; 474(7351):403-6. PubMed ID: 21572435
[TBL] [Abstract][Full Text] [Related]
38. ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.
Bose R; Karthaus WR; Armenia J; Abida W; Iaquinta PJ; Zhang Z; Wongvipat J; Wasmuth EV; Shah N; Sullivan PS; Doran MG; Wang P; Patruno A; Zhao Y; ; Zheng D; Schultz N; Sawyers CL
Nature; 2017 Jun; 546(7660):671-675. PubMed ID: 28614298
[TBL] [Abstract][Full Text] [Related]
39. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
Tomlins SA; Rhodes DR; Perner S; Dhanasekaran SM; Mehra R; Sun XW; Varambally S; Cao X; Tchinda J; Kuefer R; Lee C; Montie JE; Shah RB; Pienta KJ; Rubin MA; Chinnaiyan AM
Science; 2005 Oct; 310(5748):644-8. PubMed ID: 16254181
[TBL] [Abstract][Full Text] [Related]
40. ETS rearrangements and prostate cancer initiation.
Carver BS; Tran J; Chen Z; Carracedo-Perez A; Alimonti A; Nardella C; Gopalan A; Scardino PT; Cordon-Cardo C; Gerald W; Pandolfi PP
Nature; 2009 Feb; 457(7231):E1; discussion E2-3. PubMed ID: 19212347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
